Berlin-based Mayd, which aims to deliver medication from small pharmacies in under 30 minutes, raises a €15M seed from 468 Capital and others
Context & Ripple Effects
Mayd's €15M seed extends a decade-long funding arc for pharmacy delivery that began with PillPack's $50M raise to take on Walgreens and continued through US same-day players like Capsule and Alto. The Berlin twist is structural: rather than running its own dispensary, Mayd plugs into existing small pharmacies and promises under-30-minute delivery.
That model positions Mayd inside Berlin's healthtech cluster — Amboss raised a €30M Series B there in 2019 — and the seed proved a springboard: months later the company went on to a €30M Series A led by Lightspeed.
First-order effects
- Mayd gets runway to scale its sub-30-minute delivery network across Berlin's small pharmacies, which gain a demand channel they could not build alone.
- 468 Capital and co-investors take an early position in European quick-commerce applied to regulated goods, ahead of the larger Lightspeed round that followed.
Second-order effects
- US online pharmacies such as Capsule and Alto, which compete on pharmacist access and same-day windows, face pressure from a model that compresses delivery to minutes using partner stores instead of owned infrastructure.
- Small independent pharmacies become the contested supply side: platforms that own routing and customer relationships capture margin that previously stayed with the storefront.
Third-order effects
- If the partner-pharmacy pattern holds across Europe, pharmacy retail bifurcates into licensed dispensers competing on logistics contracts while demand aggregates at the platform layer — the consolidation path PillPack pointed at when it targeted Walgreens' turf.
- Regulated-goods delivery may pull quick-commerce beyond food into categories where licensing, not fleet size, is the barrier to entry.
The trend: Pharmacy delivery is shifting from owned-dispensary e-commerce to platform models that aggregate independent pharmacies, with Berlin emerging alongside New York and San Francisco as a funding hub for the category.